Answers are grounded in this paper and cite their sources.
This review provides a thorough analysis of adverse drug reactions (ADRs), emphasizing their categorization, and contributing variables to their emergence, diagnosis, mitigation, and evaluation.Along with more recent categories, it covers the commonly used classification system that includes type A (augmented) and type B (bizarre) reactions.The impact of several factors on the occurrence of adverse drug reactions (ADRs) is thoroughly investigated.These factors include age, gender, maternity status, fetal development, creatinine clearance, allergies, drinking and smoking habits, drug dose, frequency, polypharmacy, and disease-related factors.The identification of patient subgroups and modifications to treatment are two key strategies for reducing adverse drug reactions (ADRs).Furthermore, different ADR evaluation scales for assessing the probability of drug-related adverse events are discussed, including the WHO-UMC criteria and the Naranjo algorithm.The goal of this thorough analysis is to improve clinical ADR understanding and management.Pharmacovigilance, which is the methodical observation and assessment of adverse drug reactions (ADRs), is essential to guaranteeing the efficacy and safety of medications.It entails gathering, evaluating, and reacting to reports of possible adverse drug reactions (ADRs), helping to uncover new safety issues and improve patient care.
No takes yet. Share an insight, caveat, or question.
Shaik et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: